Single RCC Bone Metastasis Predicts Better Survival
Bone surgery should be considered in patients with solitary bone metastasis and no concomitant visceral metastases, according to investigators.
Diagnosis & Disease Information
PFS Longer With Abiraterone As Second-Line mCRPC Treatment
Clinical or radiologic progression is less likely with abiraterone plus prednisone than cabazitaxel following first-line docetaxel, study finds.
PSA, PSAD Less Predictive of Aggressive PCa in Black Men
Study finds that PSA and PSAD indicated prostate cancer above Gleason score 6 for white men only.
Adjuvant Radiation Therapy Common in MIBC
Survey finds that 46% of radiation oncologists have administered ART to patients with muscle-invasive bladder cancer on at least one occasion.
Post-Radical Cystectomy Survival Outcomes Predicted by Preop NLR
A neutrophil-to-lymphocyte ratio below 3.09 is associated with significantly longer overall and disease-specific survival.
Researchers Identify mCRPC Drug Sequence Offering the Best Survival
In a retrospective study, patients lived the longest if they received docetaxel followed by cabazitaxel and then abiraterone or enzalutamide.
Urologists Support Targeted Biopsy
In a survey, 3 in 5 urologists in the United States indicated they perform MRI-US guided biopsy in current practice.
5-Year PCa-Specific Mortality Declined With Increased PSA Testing
From 1995 to 2011, prostate cancer deaths fell by 13.0% among Danish patients diagnosed with low-risk disease.
Prostate Cancer Treatment Prolongs Survival
Study compared PCa patients who underwent surgery or radiation treatment with a matched group of non-cancer controls.
Higher BMI Lowers Death Risk in Men With Advanced Prostate Cancer
In a study, each 1-unit increment in body mass index was associated with a 16% lower mortality risk.
- Loading...
Loading...
Next post in Genitourinary Cancers Symposium
Loading... 
Loading...